Search
Alto Neuroscience Inc
ANROAdd to Watchlist
22.930USD
+0.190+0.84%
Close 06/22, 16:00（ET）Quotes delayed by 15 min
732.02MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
12
analysts
Strong Buy
Current Rating
34.800
Target Price
+53.03%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Alto Neuroscience Inc
ANRO
12
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
How have Alto Neuroscience IncANRO's recent earnings per share performed?
The market expectation was USD -0.80, while Alto Neuroscience IncANRO's earnings per share (EPS) for the previous quarter was USD -0.47. EPS for the next quarter is expected at USD -0.72.
What is the analyst rating for Alto Neuroscience Inc?
Based on the ratings of Alto Neuroscience Inc's stock from 12 analysts, most analysts support a STRONG BUY trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as STRONG BUY. Please note that this is not trading advice. You still need to conduct your own analysis.
